C83.390 Faturalandırılabilir, belirli kod Primary central nervous system lymphoma

ICD-10-CM C83.390 identifies “Primary central nervous system lymphoma” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Bölüm 2: Neoplasms

Kod talimatları

Inclusion terms4
  • PCNSL of brain
  • PCNSL of meninges
  • PCNSL of spinal cord
  • PCNSL NOS
Excludes 14
  • Primary central nervous system lymphoma, Burkitt (C83.79)
  • Primary central nervous system lymphoma, lymphoblastic (C83.59)
  • Primary central nervous system lymphoma, other (C83.89)
  • Primary central nervous system lymphoma, peripheral T-cell (C84.49)

Üst düzey talimatlar

Bölümler 2 · Neoplasms (C00-D49)

Note8
  • Functional activity
  • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
  • Morphology [Histology]
  • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
  • Primary malignant neoplasms overlapping site boundaries
  • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
  • Malignant neoplasm of ectopic tissue
  • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).

C81-C96 · Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)

Excludes 24
  • Kaposi's sarcoma of lymph nodes (C46.3)
  • secondary and unspecified neoplasm of lymph nodes (C77.-)
  • secondary neoplasm of bone marrow (C79.52)
  • secondary neoplasm of spleen (C78.89)

C83 · Non-follicular lymphoma

Excludes 11

personal history of non-Hodgkin lymphoma (Z85.72)

C83.3 · Diffuse large B-cell lymphoma

Inclusion terms7
  • Anaplastic diffuse large B-cell lymphoma
  • CD30-positive diffuse large B-cell lymphoma
  • Centroblastic diffuse large B-cell lymphoma
  • Diffuse large B-cell lymphoma, subtype not specified
  • Immunoblastic diffuse large B-cell lymphoma
  • Plasmablastic diffuse large B-cell lymphoma
  • T-cell rich diffuse large B-cell lymphoma
Excludes 12
  • mediastinal (thymic) large B-cell lymphoma (C85.2-)
  • mature T/NK-cell lymphomas (C84.-)
Resmî dizin referansları

Resmî dizin referansları (3)

Lymphoma(of) (malignant) (3)

Resmî dönüşüm geçmişi

Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.

Geçerlilik tarihleri 2024-10-01

Önceki atama: Z85.72

Geçmiş

Kod geçmişi

Son kaydedilen değişiklik · FY2025

DeğiştiDeğişmedi
FY2025

Yürürlük tarihi

  • Eklendi

Primary central nervous system lymphoma

Faturalanabilir tanı kodu

CDC/NCHS · FY2025

Tüm sürümler (5)

Tüm sürümlerYürürlük tarihiKod geçmişi
FY20252024-10-01Eklendi
FY2025 · 04-012025-04-01Tabloda değişiklik yok
FY20262025-10-01Tabloda değişiklik yok
FY2026 · April2026-04-01Tabloda değişiklik yok
FY20272026-10-01Tabloda değişiklik yok

Bu girdi, seçilen sürümde tam bir koddur. Referans kontrolü klinik uygunluğu belirlemez veya geri ödemeyi garanti etmez.